8. Riedel M., Stanek Y, Wdimisky J., Prerovsky I. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest 1982;81:151-8.

9. Bleasdale R., Frenneaux M. Prognostic importance of right ventricular dysfunction. Heart 2002;88:323-4.

10.Dartevelle P., Fadel E., Mussot S.,

et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004;23:637-48.

11. Simpson E.L., Stevenson M.D., Rawdin A., Papaioannou D. Thrombophilia testing in people with venous thromboembolism: systematic review and cost-effectiveness analysis. Health Technol Assess 2009;13(2):1-91.

12. Martinellli I., Bucciarellli P., Margaglione M., et al. The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both. Br J Haematol 2000;111:1223-9.

13. Lang I., Kerr K. Risk factors for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006;3:568-70.

14.  Lang I.M., Klepetko W., Pabinger I. No increased prevalence of the factor V mutation in chronic major vessel thromboembolic pulmonary hypertension (CTEPH). Thromb Haemost 1996;76:476-7.

15. Suntharalingam J., Goldsmith K., van Marion V., et al. Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension. Eur Respir J 2008;31:736-41.

16.Wong C.L., Szydlo R., Gibbs S., Laffan M. Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension. Blood Coagul Fibrinolysis 2010;21(3):201-6.

17. Mansilha A., Araujo F., Severo M., et al. Genetic polymorphisms and risk of recurrent deep venous thrombosis in young people: prospective cohort study. Eur J Vsc Endovasc Surg 2005;30:545-9.

18. Varela M.L., Adamczuk Y.P., Forastiero R.R., et al. Major and potential prothrombotic genotypes in a cohort of patients with venous thromboembolism. Thromb Res 2001;104:317-24.

19.Wolf M., Boyer-Neumann C., Parent F., et al. Thrombotic risk factors in pulmonary hypertension. Eur Respir J 2000;15:395-9.

20. Ginsberg J.S., Wells P.S., Brill-Edwards P., et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995;86:3685-91.

21. Бокарева И.Н., Попова Л.В., Козлова Т.В. Тромбозы и противотромботическая терапия в клинической практике. М.: МИА, 2009.

22. Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology. Eur Heart J 2000;21:1301-36.

23. Bonderman D., Turecek P.L., Jakowitsch J., et al. High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost 2003;90:372-6.

24. Koster T., BlannAD., Briet E., et al. Role of clotting factor VIII in effect ofvon Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995;345:152-5.

25. Egermayer P., Peacock A.J. Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations ofthe embolic hypothesis. Eur Respir J 2000;15:440-8.

26. Morris T.A., Marsh J.J., Chiles P.G.,

et al. High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. Blood 2009;114(9):1929-36.

27. Carr M.E. Jr., Alving B.M. Effect offibrin structure on plasmin-mediated dissolution of plasma clots. Blood Coagul Fibrinolysis 1995;6(6):567-73.

28. Fedullo P.F., Auger WR, Kerr K.M., Rubin L.J. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001;345:1465-72.

29. Bonderman D., Skoro-Sajer N., Jakowitsch J. Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation 2007;115:2153-8.

30. Bonderman D., Wilkens H., Wakounig S., et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J 2009;33(2):325-31.